FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,324,215 | -29.0% | 264,843 | 0.0% | 1.13% | -19.4% |
| Q2 2023 | $1,864,495 | +113450.2% | 264,843 | 0.0% | 1.40% | +8.7% |
| Q1 2023 | $1,642 | -2.8% | 264,843 | 0.0% | 1.29% | +7.7% |
| Q4 2022 | $1,690 | -99.9% | 264,843 | 0.0% | 1.19% | -25.4% |
| Q3 2022 | $2,272,000 | -41.4% | 264,843 | -7.0% | 1.60% | -43.2% |
| Q2 2022 | $3,874,000 | -13.5% | 284,843 | -3.2% | 2.82% | -12.6% |
| Q1 2022 | $4,480,000 | -37.6% | 294,143 | -6.4% | 3.22% | -30.4% |
| Q4 2021 | $7,184,000 | +64.2% | 314,143 | 0.0% | 4.63% | +55.6% |
| Q3 2021 | $4,376,000 | +30.5% | 314,143 | 0.0% | 2.98% | +48.5% |
| Q2 2021 | $3,352,000 | -19.0% | 314,143 | 0.0% | 2.00% | -18.4% |
| Q1 2021 | $4,140,000 | -35.0% | 314,143 | 0.0% | 2.46% | -33.0% |
| Q4 2020 | $6,368,000 | – | 314,143 | – | 3.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $28,845,000 | 16.40% |
| Birchview Capital, LP | 314,143 | $7,184,000 | 4.63% |
| Flagship Pioneering Inc. | 12,674,120 | $289,857,000 | 4.48% |
| Monashee Investment Management LLC | 240,000 | $5,489,000 | 1.36% |
| Artal Group S.A. | 1,720,720 | $39,353,000 | 1.07% |
| EAM Investors, LLC | 149,280 | $3,414,000 | 0.56% |
| EAM Global Investors LLC | 103,241 | $2,361,000 | 0.42% |
| Alphabet Inc. | 500,901 | $11,456,000 | 0.28% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 54,341 | $1,243,000 | 0.14% |
| Sunbelt Securities, Inc. | 24,740 | $334,000 | 0.05% |